| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Medical Officer | Chief Medical Officer
1 company
Sophia Randolph last filed a Form 4 in August 2024, as Chief Medical Officer at ALXO. Sophia Randolph's net worth is not public. Form 4 filings only show shares in the companies where this person was an insider, as of the last filing.
Historically, Sophia Randolph's trades have earned a strong insider score of 88/100 across 15 rated trades. Over a 12-month horizon, 93.3% of those trades were profitable, with an average 12-month return of +70.7%.
At the last filing, the largest reported position was 325,711 shares of ALXO. The ALXO filings lean toward selling, a net 96,968 shares.
Sophia Randolph has 23 Form 4 filings on record from July 2020 to August 2024, all as Chief Medical Officer at Alx Oncology (ALXO), 2020–2024.
The 51 reported transactions were 34 open-market sales, 9 option exercises, 5 option or other derivative awards and 3 stock awards.
Counted by filing, the open-market trades come to no purchases and 15 sales worth about $4.6M.
The largest open-market sale was 7,387 shares of ALXO at an average $77.66 on September 10, 2021, about $574K. Twelve months later ALXO was down 83%.
1 of the 5 sales since April 2023 was made under a Rule 10b5-1 trading plan; the other 4 were not.
Shares as reported in the last Form 4 for each company; the most recent is from August 2024. Values use today's prices. Any trades after the last filing were not reported, so current holdings may differ.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Aug 14, 2024 | ALXO Alx Oncology Holdings Inc | Chief Medical Officer | Sell | 1,365 | $2.58 | $3,521.70 | -0.4% | -48.1% | -74.6% | |
| Jul 1, 2024 | ALXO Alx Oncology Holdings Inc | Chief Medical Officer | Sell | 3,273 | $5.82 | $19,044.93 | -1.0% | -69.6% | -92.8% | |
| May 13, 2024 | ALXO Alx Oncology Holdings Inc | Chief Medical Officer | Sell10b5-1 | 12,000 | $15.94 | $191,338.70 | -3.5% | -83.9% | -96.9% | |
| Dec 29, 2023 | ALXO Alx Oncology Holdings Inc | Chief Medical Officer | Sell | 3,128 | $15.04 | $47,045.12 | -1.0% | -25.1% | -89.1% | |
| Jun 30, 2023 | ALXO Alx Oncology Holdings Inc | Chief Medical Officer | Sell | 1,605 | $7.34 | $11,780.70 | -0.6% | -34.1% | -19.7% | |
| Dec 29, 2022 | ALXO Alx Oncology Holdings Inc | Chief Medical Officer | Sell | 1,617 | $11.07 | $17,900.84 | -0.6% | -56.4% | +29.9% | |
| Nov 22, 2021 | ALXO Alx Oncology Holdings Inc | Chief Medical Officer | Sale+OE | 14,884 | $36.77 | $547,314.45 | -8.3% | -57.5% | -70.8% | |
| Oct 11, 2021 | ALXO Alx Oncology Holdings Inc | Chief Medical Officer | Sell | 7,387 | $60.97 | $450,421.63 | -4.7% | -67.8% | -82.9% | |
| Sep 10, 2021 | ALXO Alx Oncology Holdings Inc | Chief Medical Officer | Sell | 7,387 | $77.66 | $573,670.48 | -4.5% | -60.7% | -83.2% | |
| Aug 10, 2021 | ALXO Alx Oncology Holdings Inc | Chief Medical Officer | Sell | 7,387 | $64.63 | $477,438.86 | -4.3% | -19.8% | -80.3% |